About The Ohio State University AIDS CRS (2301)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at The Ohio State University AIDS CRS (2301)
During the past decade, The Ohio State University AIDS CRS (2301) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate Cancer
1994-10-01
2018-05-14
Completed
2,028
Chemotherapy in Treating Women With Breast Cancer That Can Be Surgically Removed
1995-12-01
2010-02-01
Completed
2,411
Radiation Therapy With or Without Radiosurgery in Treating Patients With Brain Metastases
1996-01-01
2004-12-01
Completed
333
Aminocamptothecin in Treating Patients With Refractory or Recurrent Hodgkin's Disease or Non-Hodgkin's Lymphoma
1996-04-01
2008-01-01
Completed
37
Radiation Therapy With or Without Bicalutamide for Recurrent pT3N0 Prostate Cancer After Radical Prostatectomy
1998-02-01
2022-05-20
Completed
840
Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
1998-02-01
Completed
949
Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer
1998-09-01
2010-06-01
Completed
243
Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery
1998-07-01
2009-04-01
Completed
366
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "The Ohio State University AIDS CRS (2301)"
#1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 5 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at The Ohio State University AIDS CRS (2301)
According to Clinical.Site data, the most researched conditions in "The Ohio State University AIDS CRS (2301)" are
"HIV Infections" (3 trials), "HIV Infection" (1 trials) and "HIV-1 Infection" (1 trials). Many other conditions were trialed in "The Ohio State University AIDS CRS (2301)" in a lesser frequency.
Clinical Trials Intervention Types at The Ohio State University AIDS CRS (2301)
Most popular intervention types in "The Ohio State University AIDS CRS (2301)" are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Atazanavir" (1 trials), "Darunavir" (1 trials), "Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate" (1 trials), "Emtricitabine/tenofovir disoproxil fumarate" (1 trials) and "Placebo control for Trimer 4571 vaccine 100mcg with 500mcg alum adjuvant" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The Ohio State University AIDS CRS (2301)
The vast majority of trials in "The Ohio State University AIDS CRS (2301)" are
5 trials for "All" genders.
Clinical Trials Status at The Ohio State University AIDS CRS (2301)
Currently, there are NaN active trials in "The Ohio State University AIDS CRS (2301)".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in The Ohio State University AIDS CRS (2301),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The Ohio State University AIDS CRS (2301), 2 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".